Pentosan polysulfate sodium
Sponsors
Paradigm Biopharmaceuticals (USA) Inc., Radiation Therapy Oncology Group, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., The University of Texas Health Science Center, Houston
Conditions
Bipolar DisorderDiarrheaKnee osteoarthritis painProstatitisPsychotic DisordersRadiation EnteritisSchizoaffective DisorderSchizophrenia
Phase 2
An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland
CompletedNCT00236990
End: 2005-09-30Updated: 2011-07-01
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
CompletedNCT02930005
Start: 2015-08-07End: 2016-10-06Updated: 2019-03-26
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain
WithdrawnCTIS2022-500228-31-00
Target: 40Updated: 2022-06-27
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain
CompletedCTIS2022-500228-31-01
Start: 2023-03-31End: 2023-11-09Target: 80Updated: 2023-03-03